Skip to main content
OpenTrials
Completed

NCT Number: NCT02674672

A Safety and Efficacy Study for Implantation and Retrieval Procedures Using the VENATECH® Retrieval Filter System

To establish the clinical safety and efficacy of the VenaTech® Retrievable Vena Cava Filter

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hopital européen Georges Pompidou

Paris, 75908, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pulmonary thrombo-embolism with contraindication to anticoagulation.
  • Failure of anticoagulant therapy in thrombo-embolic diseases.
  • Prevention of pulmonary embolism in patients with a recent history ( <3 months) of DVT/ PE who need to undergo urgent surgery at high risk of DVT/PE with temporary contra-indication to the use of therapeutic doses of anticoagulants.
  • Emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced and
  • Chronic, recurrent pulmonary embolism where anticoagulant therapy has failed or is contraindicated

Exclusion criteria

  • The filter should not be implanted in patients with :
  • A vena cava which has a diameter < 14 mm or > 28 mm (due to the risk of device migration)
  • Risk of septic embolism
  • Known allergy to the materials contained in the kit, allergy to contrast media.
  • Severely disabled patients whose life-expectancy, up to 6 months, appears limited according to the investigator's opinion.

In addition, exclusion criteria are also extended to :

  • Patients who cannot be regularly followed up by the participating center
  • Subject who already has an implanted vena cava filter
  • Subject who has a duplicated IVC
  • Subject who has a contrast allergy to both iodinated contrast and non-iodinated contrast material
  • Subject unable to understand information about participation in the study due to a language barrier, intellectual deficiency, psychiatric problems…
  • Subject who has a renal failure (creatinemia clearance < 30ml/min)

Treatment and study plan

VenaTech® (VenaTech Retrievable Filter)

Device

Primary outcomes

  1. Safety and the efficacy of filter implantation and retrieval by the study of technical success rate of filter placement, and filter removal (when filter removal procedure is schedule) within 12 weeks of implantation

    Time frame: 12 weeks

Sponsors and collaborators

Lead sponsor

B.Braun Médical - CoE Chasseneuil

Industry

Registry information

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Feb 4, 2016
Registry last updated
Feb 3, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.